News
Feb 01, 2021
AlveoliX in the Swiss Venture Capital Report 2021!
Despite the covid-19 crisis and no mega-rounds of investment in 2020, Biotech start-ups are back at the top!Swiss Biotech startups collected more than CHF 800 million in 2020, an increase of 31% compared to 2019. This is linked to the fact that innovation in drug development is taking place in the long term and, to...
Dec 14, 2020
AlveoliX has a new Business Developer, Léa Todeschini
We are very excited to welcome Léa Todeschini as Business Developer in our team! Léa will be responsible for the growth and development of new business while maintaining customer relationships. We are looking forward to grow and further develop our company together with Léa. If you happen to be near our office, stop by and...
Dec 02, 2020
Video & Article – Reproducing pulmonary function in the lab
Here is the team behind the scene! Big thanks to Innosuisse for their support and helping us bringing our chip one step closer to society.Check out the article: Reproducing pulmonary function in the lab Video: © Innosuisse / FDFA Presence Switzerland
Oct 05, 2020
Théo Imler just graduates as MSc. in Life Sciences and Engineering from EPFL
Congratulations to Théo Imler for his graduation as MSc. in Life Sciences and Engineering by EPFL!Théo did an excellent defense of his MSc. Thesis project, focused on developing and characterizing a novel cellular model for modeling Vascular Leak Syndrome on the AlveoliX Lung-On-Chip.Congrats on this great achievement!
